small molecule

TISSUEBLUE

BRILLIANT BLUE G

Loss of exclusivityDecember 2026FDA regulatory exclusivity expiry

CompanyDUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV

Drug detail

Brand name	TISSUEBLUE
Active ingredient	BRILLIANT BLUE G
Strength	0.025%
Dosage form	SOLUTION
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	December 2019
Marketing status	RX

Regulatory exclusivity

Code	Expires
ODE-282	December 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.